发明名称 |
REMEDIES FOR SEPSIS |
摘要 |
Treatment for sepsis involves administration of an opioid kappa receptor agonist. ACTIVITY : Antibacterial; Immunosuppressive; Hypertensive; Anticoagulant; Thrombolytic. In a lipopolysaccharide induced toxemia model in ICR mice, administration of (-)-17-(cyclopropylmethyl)-3,14-beta -dihydroxy-4,5alpha -epoxy-6-beta -[N-methyl-trans-3-(3-furyl)acrylamido]morphinane hydrochloric acid salt at 100 Microg orally increased the percentage of mice surviving after 24 hours from 30% for a control, to 80%. The corresponding values after 48 hours were 10% and 40% respectively. MECHANISM OF ACTION : Opioid Agonist-Kappa. |
申请公布号 |
EP1402899(A4) |
申请公布日期 |
2009.03.11 |
申请号 |
EP20020724723 |
申请日期 |
2002.05.08 |
申请人 |
TORAY INDUSTRIES, INC. |
发明人 |
SUZUKI, TOMOHIKO;INADA, HIDEAKI;YOSHIZAWA, YOSHITAKA;KAWAMURA, KUNIAKI;TANAKA, TOSHIAKI |
分类号 |
A61K45/00;A61K31/40;A61K31/485;A61K38/00;A61P7/08;A61P31/04;C07D295/12;C07D489/08;C07K5/10;C07K5/107 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|